Literature DB >> 387466

Drug-induced lysosomal storage disorders.

R Lüllmann-Rauch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387466

Source DB:  PubMed          Journal:  Front Biol        ISSN: 0071-965X


× No keyword cloud information.
  8 in total

1.  Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis.

Authors:  Lucette Doessegger; Georg Schmitt; Barbara Lenz; Holger Fischer; Götz Schlotterbeck; Elke-Astrid Atzpodien; Hans Senn; Laura Suter; Miklos Csato; Stefan Evers; Thomas Singer
Journal:  Ther Adv Drug Saf       Date:  2013-06

2.  Amantadine can induce intra-epithelial deposition in the cornea.

Authors:  Asayo Yoshinaka; Taiichiro Chikama; Yoshiaki Kiuchi
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-05

3.  Neuropathy and fatal hepatitis in a patient receiving amiodarone.

Authors:  P K Lim; P N Trewby; G C Storey; D W Hole
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-02

4.  Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.

Authors:  N Andrieu; R Salvayre; T Levade
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

Review 5.  Acid phospholipase A1 in liver--a brief survey.

Authors:  H Kunze; B M Löffler
Journal:  Klin Wochenschr       Date:  1989-02-01

6.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

7.  Successful drug development despite adverse preclinical findings part 2: examples.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; Makoto Hayashi; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

8.  Pathology and Neurotoxicity in Dogs after Repeat Dose Exposure to a Serotonin 5-HT1B Inhibitor.

Authors:  Jane C F Chang; Paul Ciaccio; Patricia Schroeder; Lindsay Wright; Russell Westwood; Anna-Lena Berg
Journal:  J Toxicol Pathol       Date:  2014-04-30       Impact factor: 1.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.